Hi @GinoE thanks for your response. I am a little confused as to...

Hi @GinoE thanks for your response. I am a little confused as to the timeline for this announcement. I note that in the November presentation this slide was published.


So it says “First patient in “. That is pretty clear and was stated by our CEO LC, whom I love. Yet on a subsequent slide is shown…..


MAST in combination with pembrolizumab. The slide goes on to say 34 heavily pretreated patients dosed to date November 2023.
Oh well, in a couple of hours perhaps all will be clear and will put a rocket under our share price, and keep my wife in diamonds, and me in Selosse champagne.